Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD's The Liver Meeting®

Core Insights - Mirum Pharma demonstrates leadership in liver disease innovation by presenting data from its LIVMARLI® and Volixibat clinical programs at AASLD's The Liver Meeting® [1] Group 1 - Mirum Pharma showcases its advancements in liver disease treatment through clinical data [1] - The presentation at AASLD's The Liver Meeting® highlights the company's commitment to addressing liver diseases [1]